# C_2016362EN.01000101.xml

| 30.9.2016 | EN | Official Journal of the European Union | C 362/1 |
| --- | --- | --- | --- |

30.9.2016

EN

Official Journal of the European Union

C 362/1

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2016 to 31 August 2016

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

1

(2016/C 362/01)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Issuing of a marketing authorization

Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 16.8.2016 | Cinqaero | reslizumab | Teva Pharmaceuticals Limited
  Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX, United Kingdom | EU/1/16/1125 | Concentrate for solution for infusion | R03DX08 | 18.8.2016 |
| 18.8.2016 | Aerivio Spiromax | salmeterol/fluticasone propionate | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/16/1122 | Inhalation powder | R03AK06 | 22.8.2016 |
| 18.8.2016 | Airexar Spiromax | salmeterol/fluticasone propionate | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/16/1123 | Inhalation powder | R03AK06 | 22.8.2016 |
| 18.8.2016 | Nordimet | methotrexate | Nordic Group B.V.
  Siriusdreef 22, NL-2132 WT Hoofddorp, Nederland | EU/1/16/1124 | Solution for injection | L01BA01 | 22.8.2016 |
| 18.8.2016 | Zalmoxis | Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2) | MolMed S.p.A.
  Via Olgettina 58, I-20132 Milano, Italia | EU/1/16/1121 | Dispersion for infusion | Pending | 23.8.2016 |
| 22.8.2016 | Atazanavir Mylan | atazanavir | Mylan S.A.S
  117 allée des Parcs, F-69800 Saint Priest, France | EU/1/16/1091 | Capsule, hard | J05AE08 | 24.8.2016 |
| 25.8.2016 | Kisplyx | lenvatinib | Eisai Europe Limited
  European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN, United Kingdom | EU/1/16/1128 | Capsule, hard | L01XE29 | 30.8.2016 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

16.8.2016

Cinqaero

reslizumab

Teva Pharmaceuticals Limited

Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX, United Kingdom

EU/1/16/1125

Concentrate for solution for infusion

R03DX08

18.8.2016

18.8.2016

Aerivio Spiromax

salmeterol/fluticasone propionate

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/16/1122

Inhalation powder

R03AK06

22.8.2016

18.8.2016

Airexar Spiromax

salmeterol/fluticasone propionate

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/16/1123

Inhalation powder

R03AK06

22.8.2016

18.8.2016

Nordimet

methotrexate

Nordic Group B.V.

Siriusdreef 22, NL-2132 WT Hoofddorp, Nederland

EU/1/16/1124

Solution for injection

L01BA01

22.8.2016

18.8.2016

Zalmoxis

Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)

MolMed S.p.A.

Via Olgettina 58, I-20132 Milano, Italia

EU/1/16/1121

Dispersion for infusion

Pending

23.8.2016

22.8.2016

Atazanavir Mylan

atazanavir

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/16/1091

Capsule, hard

J05AE08

24.8.2016

25.8.2016

Kisplyx

lenvatinib

Eisai Europe Limited

European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN, United Kingdom

EU/1/16/1128

Capsule, hard

L01XE29

30.8.2016

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Modification of a marketing authorization

Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 1.8.2016 | Aripiprazole Mylan Pharma | Mylan S.A.S
  117 allée des Parcs, F-69800 Saint Priest, France | EU/1/15/1005 | 3.8.2016 |
| 1.8.2016 | Ilaris | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/09/564 | 3.8.2016 |
| 1.8.2016 | Pegasys | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/02/221 | 3.8.2016 |
| 1.8.2016 | Pradaxa | Boehringer Ingelheim International GmbH
  Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland | EU/1/08/442 | 3.8.2016 |
| 1.8.2016 | Rasagiline ratiopharm | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/14/977 | 3.8.2016 |
| 1.8.2016 | XALKORI | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/12/793 | 3.8.2016 |
| 8.8.2016 | Desloratadine ratiopharm | ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/11/746 | 10.8.2016 |
| 8.8.2016 | Desloratadine Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/11/732 | 10.8.2016 |
| 8.8.2016 | Levetiracetam Actavis Group | Actavis Group PTC ehf.
  Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Ísland | EU/1/11/738 | 10.8.2016 |
| 8.8.2016 | Plenadren | Shire Services BVBA
  rue Montoyer 47, 1000 Bruxelles, Belgique/Montoyerstraat 47, 1000 Brussel, België | EU/1/11/715 | 10.8.2016 |
| 8.8.2016 | Zavesca | Actelion Registration Ltd
  Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom | EU/1/02/238 | 10.8.2016 |
| 9.8.2016 | IDflu | Sanofi Pasteur SA
  2 avenue Pont Pasteur, F-69007 Lyon, France | EU/1/08/507 | 11.8.2016 |
| 9.8.2016 | Intanza | Sanofi Pasteur MSD SNC
  162 avenue Jean Jaurès, 69007 Lyon, France | EU/1/08/505 | 11.8.2016 |
| 9.8.2016 | Kaletra | AbbVie Ltd
  Maidenhead, SL6 4UB, United Kingdom | EU/1/01/172 | 11.8.2016 |
| 9.8.2016 | Memantine ratiopharm | ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/13/836 | 11.8.2016 |
| 12.8.2016 | Ibandronic acid Accord | Accord Healthcare Limited
  Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom | EU/1/12/798 | 17.8.2016 |
| 12.8.2016 | Imvanex | Bavarian Nordic A/S
  Hejreskovvej 10a, DK-3490 Kvistgaard, Danmark | EU/1/13/855 | 17.8.2016 |
| 12.8.2016 | Myclausen | Passauer Pharma GmbH
  Eiderstedter Weg 3, 14129 Berlin, Deutschland | EU/1/10/647 | 17.8.2016 |
| 12.8.2016 | Scenesse | Clinuvel UK Limited
  Devonshire House, 60 Goswell Road, London EC1M 7AD, United Kingdom | EU/1/14/969 | 17.8.2016 |
| 16.8.2016 | Aflunov | Seqirus S.r.l.
  Via Fiorentina, 1, Siena, Italia | EU/1/10/658 | 18.8.2016 |
| 16.8.2016 | Dasselta | Krka, d. d., Novo Mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/11/739 | 18.8.2016 |
| 16.8.2016 | Eylea | Bayer Pharma AG
  D-13342 Berlin, Deutschland | EU/1/12/797 | 18.8.2016 |
| 16.8.2016 | HALAVEN | Eisai Europe Limited
  European Knowledge Centre, Mosquito Way, Hatfield, Herts AL10 9SN, United Kingdom | EU/1/11/678 | 18.8.2016 |
| 16.8.2016 | Mekinist | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/14/931 | 18.8.2016 |
| 18.8.2016 | Kaletra | AbbVie Ltd
  Maidenhead, SL6 4UB, United Kingdom | EU/1/01/172 | 22.8.2016 |
| 18.8.2016 | KEYTRUDA | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/15/1024 | 22.8.2016 |
| 18.8.2016 | OLYSIO | Janssen-Cilag International NV
  Turnhoutseweg 30, B-2340 Beerse, België | EU/1/14/924 | 22.8.2016 |
| 18.8.2016 | Sevelamer carbonate Zentiva | Genzyme Europe B.V.
  Gooimeer 10, NL-1411 DD Naarden, Nederland | EU/1/14/952 | 22.8.2016 |
| 18.8.2016 | Tracleer | Actelion Registration Ltd
  Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom | EU/1/02/220 | 22.8.2016 |
| 18.8.2016 | Truvada | Gilead Sciences International Ltd.
  Cambridge, CB21 6GT, United Kingdom | EU/1/04/305 | 22.8.2016 |
| 18.8.2016 | Vargatef | Boehringer Ingelheim International GmbH
  Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland | EU/1/14/954 | 22.8.2016 |
| 18.8.2016 | Viekirax | AbbVie Ltd
  Maidenhead, SL6 4UB, United Kingdom | EU/1/14/982 | 22.8.2016 |
| 22.8.2016 | Brimica Genuair | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/14/963 | 24.8.2016 |
| 22.8.2016 | Dificlir | Astellas Pharma Europe B.V.
  Sylviusweg 62, NL-2333 BE Leiden, Nederland | EU/1/11/733 | 24.8.2016 |
| 22.8.2016 | Duaklir Genuair | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/14/964 | 24.8.2016 |
| 22.8.2016 | Lumark | IDB Holland B.V.
  Weverstraat 17, 5111 PV Baarle-Nassau, Nederland | EU/1/15/1013 | 24.8.2016 |
| 22.8.2016 | Nimenrix | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/12/767 | 24.8.2016 |
| 22.8.2016 | Tasmar | Meda AB
  Pipers väg 2A, S-170 09 Solna, Sverige | EU/1/97/044 | 24.8.2016 |
| 25.8.2016 | Iclusig | ARIAD Pharma Ltd
  Riverbridge House, Guildford Road, Leatherhead, Surrey KT22 9AD, United Kingdom | EU/1/13/839 | 30.8.2016 |
| 25.8.2016 | IMBRUVICA | Janssen-Cilag International NV
  Turnhoutseweg 30, B-2340 Beerse, België | EU/1/14/945 | 29.8.2016 |
| 25.8.2016 | Orencia | Bristol-Myers Squibb Pharma EEIG
  Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom | EU/1/07/389 | 30.8.2016 |
| 25.8.2016 | Renvela | Genzyme Europe B.V.
  Gooimeer 10, NL-1411 DD Naarden, Nederland | EU/1/09/521 | 29.8.2016 |
| 25.8.2016 | Revestive | Shire Pharmaceuticals Ireland Limited
  5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland | EU/1/12/787 | 29.8.2016 |
| 25.8.2016 | Tasermity | Genzyme Europe B.V.
  Gooimeer 10, NL-1411 DD Naarden, Nederland | EU/1/14/953 | 29.8.2016 |
| 25.8.2016 | VPRIV | Shire Pharmaceuticals Ireland Limited
  5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland | EU/1/10/646 | 29.8.2016 |
| 25.8.2016 | XALKORI | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/12/793 | 30.8.2016 |
| 25.8.2016 | Zurampic | Grünenthal GmbH
  Zieglerstrasse 6, D-52078, Aachen, Deutschland | EU/1/15/1080 | 29.8.2016 |
| 31.8.2016 | Ketoconazole HRA | Laboratoire HRA Pharma
  15 rue Béranger, F-75003 Paris, France | EU/1/14/965 | 2.9.2016 |
| 31.8.2016 | Renagel | Genzyme Europe B.V.
  Gooimeer 10, NL-1411 DD Naarden, Nederland | EU/1/99/123 | 2.9.2016 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

1.8.2016

Aripiprazole Mylan Pharma

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/15/1005

3.8.2016

1.8.2016

Ilaris

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/09/564

3.8.2016

1.8.2016

Pegasys

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/221

3.8.2016

1.8.2016

Pradaxa

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/08/442

3.8.2016

1.8.2016

Rasagiline ratiopharm

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/14/977

3.8.2016

1.8.2016

XALKORI

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/12/793

3.8.2016

8.8.2016

Desloratadine ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/11/746

10.8.2016

8.8.2016

Desloratadine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/732

10.8.2016

8.8.2016

Levetiracetam Actavis Group

Actavis Group PTC ehf.

Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Ísland

EU/1/11/738

10.8.2016

8.8.2016

Plenadren

Shire Services BVBA

rue Montoyer 47, 1000 Bruxelles, Belgique/Montoyerstraat 47, 1000 Brussel, België

EU/1/11/715

10.8.2016

8.8.2016

Zavesca

Actelion Registration Ltd

Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

EU/1/02/238

10.8.2016

9.8.2016

IDflu

Sanofi Pasteur SA

2 avenue Pont Pasteur, F-69007 Lyon, France

EU/1/08/507

11.8.2016

9.8.2016

Intanza

Sanofi Pasteur MSD SNC

162 avenue Jean Jaurès, 69007 Lyon, France

EU/1/08/505

11.8.2016

9.8.2016

Kaletra

AbbVie Ltd

Maidenhead, SL6 4UB, United Kingdom

EU/1/01/172

11.8.2016

9.8.2016

Memantine ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/13/836

11.8.2016

12.8.2016

Ibandronic acid Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/12/798

17.8.2016

12.8.2016

Imvanex

Bavarian Nordic A/S

Hejreskovvej 10a, DK-3490 Kvistgaard, Danmark

EU/1/13/855

17.8.2016

12.8.2016

Myclausen

Passauer Pharma GmbH

Eiderstedter Weg 3, 14129 Berlin, Deutschland

EU/1/10/647

17.8.2016

12.8.2016

Scenesse

Clinuvel UK Limited

Devonshire House, 60 Goswell Road, London EC1M 7AD, United Kingdom

EU/1/14/969

17.8.2016

16.8.2016

Aflunov

Seqirus S.r.l.

Via Fiorentina, 1, Siena, Italia

EU/1/10/658

18.8.2016

16.8.2016

Dasselta

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/739

18.8.2016

16.8.2016

Eylea

Bayer Pharma AG

D-13342 Berlin, Deutschland

EU/1/12/797

18.8.2016

16.8.2016

HALAVEN

Eisai Europe Limited

European Knowledge Centre, Mosquito Way, Hatfield, Herts AL10 9SN, United Kingdom

EU/1/11/678

18.8.2016

16.8.2016

Mekinist

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/14/931

18.8.2016

18.8.2016

Kaletra

AbbVie Ltd

Maidenhead, SL6 4UB, United Kingdom

EU/1/01/172

22.8.2016

18.8.2016

KEYTRUDA

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/15/1024

22.8.2016

18.8.2016

OLYSIO

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/14/924

22.8.2016

18.8.2016

Sevelamer carbonate Zentiva

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/14/952

22.8.2016

18.8.2016

Tracleer

Actelion Registration Ltd

Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

EU/1/02/220

22.8.2016

18.8.2016

Truvada

Gilead Sciences International Ltd.

Cambridge, CB21 6GT, United Kingdom

EU/1/04/305

22.8.2016

18.8.2016

Vargatef

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/14/954

22.8.2016

18.8.2016

Viekirax

AbbVie Ltd

Maidenhead, SL6 4UB, United Kingdom

EU/1/14/982

22.8.2016

22.8.2016

Brimica Genuair

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/963

24.8.2016

22.8.2016

Dificlir

Astellas Pharma Europe B.V.

Sylviusweg 62, NL-2333 BE Leiden, Nederland

EU/1/11/733

24.8.2016

22.8.2016

Duaklir Genuair

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/964

24.8.2016

22.8.2016

Lumark

IDB Holland B.V.

Weverstraat 17, 5111 PV Baarle-Nassau, Nederland

EU/1/15/1013

24.8.2016

22.8.2016

Nimenrix

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/12/767

24.8.2016

22.8.2016

Tasmar

Meda AB

Pipers väg 2A, S-170 09 Solna, Sverige

EU/1/97/044

24.8.2016

25.8.2016

Iclusig

ARIAD Pharma Ltd

Riverbridge House, Guildford Road, Leatherhead, Surrey KT22 9AD, United Kingdom

EU/1/13/839

30.8.2016

25.8.2016

IMBRUVICA

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/14/945

29.8.2016

25.8.2016

Orencia

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/07/389

30.8.2016

25.8.2016

Renvela

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/09/521

29.8.2016

25.8.2016

Revestive

Shire Pharmaceuticals Ireland Limited

5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/12/787

29.8.2016

25.8.2016

Tasermity

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/14/953

29.8.2016

25.8.2016

VPRIV

Shire Pharmaceuticals Ireland Limited

5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/10/646

29.8.2016

25.8.2016

XALKORI

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/12/793

30.8.2016

25.8.2016

Zurampic

Grünenthal GmbH

Zieglerstrasse 6, D-52078, Aachen, Deutschland

EU/1/15/1080

29.8.2016

31.8.2016

Ketoconazole HRA

Laboratoire HRA Pharma

15 rue Béranger, F-75003 Paris, France

EU/1/14/965

2.9.2016

31.8.2016

Renagel

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/99/123

2.9.2016

—   Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Issuing of a marketing authorization

Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 12.8.2016 | Sedadex | dexmedetomidine | Le Vet Beheer B.V.
  Wilgenweg 7, NL-3421 TV Oudewater, Nederland | EU/2/16/198 | Solution for injection | QN05CM18 | 17.8.2016 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

12.8.2016

Sedadex

dexmedetomidine

Le Vet Beheer B.V.

Wilgenweg 7, NL-3421 TV Oudewater, Nederland

EU/2/16/198

Solution for injection

QN05CM18

17.8.2016

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Modification of a marketing authorization

Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 9.8.2016 | Recocam | Cross Vetpharm Group, Ltd
  Broomhill Road, Tallaght Dublin 24, Ireland | EU/2/11/133 | 11.8.2016 |
| 12.8.2016 | Metacam | Boehringer Ingelheim Vetmedica GmbH
  D-55216 Ingelheim am Rhein, Deutschland | EU/2/97/004 | 17.8.2016 |
| 26.8.2016 | Panacur AquaSol | Intervet International B.V.
  Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland | EU/2/11/135 | 30.8.2016 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

9.8.2016

Recocam

Cross Vetpharm Group, Ltd

Broomhill Road, Tallaght Dublin 24, Ireland

EU/2/11/133

11.8.2016

12.8.2016

Metacam

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/97/004

17.8.2016

26.8.2016

Panacur AquaSol

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/11/135

30.8.2016

—   Withdrawal of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

Withdrawal of a marketing authorization

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 22.8.2016 | Velactis | Ceva Santé Animale
  10 av. de La Ballastière, 33500 Libourne, France | EU/2/15/192 | 24.8.2016 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

22.8.2016

Velactis

Ceva Santé Animale

10 av. de La Ballastière, 33500 Libourne, France

EU/2/15/192

24.8.2016

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| European Medicines Agency |
| --- |
| 30 Churchill Place |
| Canary Wharf |
| London E14 5EU |
| United Kingdom |

European Medicines Agency

30 Churchill Place

Canary Wharf

London E14 5EU

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

1

---